- AU$112.81m
- AU$106.49m
- AU$37.06m
- 72
- 38
- 100
- 78
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.32 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 737.31 | ||
| Price to Sales | 3.17 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -5.61% | ||
| Return on Equity | -5.63% | ||
| Operating Margin | -14.67% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 18.61 | 25.88 | 34.35 | 40.4 | 37.06 | 40.4 | 43.13 | 17.05% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Alcidion Group Limited is a healthcare technology company. The Company's principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. The Company's other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users.
Directors
- Rebecca Wilson NEC
- Kate Quirke CEO
- Matthew Gepp CFO
- Melanie Leydin SEC
- Michael Sapountzis SEC
- Malcolm Pradhan DRC
- Simon Chamberlain NED
- Daniel Sharp NID
- Victoria Weekes NID
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 15th, 2010
- Public Since
- June 24th, 2011
- No. of Shareholders
- 8,722
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 1,342,952,696
- Address
- L 10 9 Yarra Street, South Yarra, MELBOURNE, 3141
- Web
- https://www.alcidion.com/
- Phone
- +61 380606177
- Auditors
- William Buck
Upcoming Events for ALC
Similar to ALC
3P Learning
Australian Stock Exchange - SEATS
5G Networks
Australian Stock Exchange - SEATS
8Common
Australian Stock Exchange - SEATS
ActivePort
Australian Stock Exchange - SEATS
Adisyn
Australian Stock Exchange - SEATS
FAQ
What is the Alcidion share price?
As of Today at 01:09 UTC, shares in Alcidion are trading at AU$0.08. This share price information is delayed by 15 minutes.
How has the Alcidion share price performed this year?
Shares in Alcidion last closed at AU$0.08 and the price had moved by +55.56% over the past 365 days. In terms of relative price strength the Alcidion share price has outperformed the ASX All Ordinaries Index by +49.13% over the past year.
What are the analyst and broker recommendations for Alcidion?
The overall consensus recommendation for Alcidion is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Alcidion dividend yield?
Alcidion does not currently pay a dividend.
Does Alcidion pay a dividend?
Alcidion does not currently pay a dividend.
When does Alcidion next pay dividends?
Alcidion does not currently pay a dividend.
How do I buy Alcidion shares?
To buy shares in Alcidion you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Alcidion?
As of the previous close price of AU$0.08, shares in Alcidion had a market capitalisation of AU$112.81m.
Where are Alcidion shares listed?
Here are the trading details for Alcidion:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: ALC
What kind of share is Alcidion?
Based on an overall assessment of its quality, value and momentum Alcidion is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Alcidion share price forecast for 2025?
The analyst consensus target price for shares in Alcidion is AU$0.11. That is 34.52% above the last closing price of AU$0.08.
Analysts covering Alcidion currently have a consensus Earnings Per Share (EPS) forecast of -AU$0.00 for the next financial year.
Find out moreWhat is the trend in the Alcidion share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Alcidion. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +55.56%.
As of the last closing price of AU$0.08, shares in Alcidion were trading +23.43% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Alcidion PE Ratio?
The Alcidion PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.08.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Alcidion?
Alcidion's management team is headed by:
- Rebecca Wilson - NEC
- Kate Quirke - CEO
- Matthew Gepp - CFO
- Melanie Leydin - SEC
- Michael Sapountzis - SEC
- Malcolm Pradhan - DRC
- Simon Chamberlain - NED
- Daniel Sharp - NID
- Victoria Weekes - NID